OUTRUN TX
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
OUTRUN TX
Industry:
Health Care Medical Therapeutics
Address:
Dundee, Dundee City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.outruntx.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Investors List
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Seed Round - Outrun TX
Official Site Inspections
http://www.outruntx.com
- Host name: 59.0.153.160.host.secureserver.net
- IP address: 160.153.0.59
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Outrun TX"
Outrun Therapeutics – Unlocking the therapeutic …
Apr 18, 2024 Our Approach. Outrun Therapeutics is a preclinical biotech using E3 ligase inhibition to unlock the therapeutic potential of protein stabilisation for the treatment of cancer and other diseases.See details»
Our Company – Outrun Therapeutics
Kuan-Chuan (Eric) is a scientist with over 10 years of experience in both chemical and cell biology disciplines. Kuan-Chuan’s experience includes a PhD at MRC-PPU at the University of Dundee, post-doctoral research at UC Berkley and a …See details»
Outrun TX - Crunchbase Company Profile & Funding
Organization. Outrun TX . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Contact Email [email protected]; Outrun TX develops a …See details»
Outrun Therapeutics - LinkedIn
Outrun Therapeutics will be in Cavtat-Dubrovnik, Croatia from the 27 September to 1 October, attending the 'Ubiquitin and ubiquitin-like proteins in health and disease' EMBO workshop. …See details»
Outrun TX Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Outrun TX. Use the PitchBook Platform to explore the full profile.See details»
Outrun Therapeutics launches with a $10m seed financing from M …
Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck. From …See details»
Outrun TX - Products, Competitors, Financials, Employees, …
Outruntx.com. Overview & Products; Financials; People; Founded Year 2019. Stage Seed VC | Alive. Total Raised $10M. Last Raised $10M | 7 mos ago. About Outrun TX. Outrun TX …See details»
Outrun Therapeutics - VentureRadar
Similar Companies: Nurix USA Publicly Traded Nurix, Inc. is a leader in discovering and developing therapies that modulate the ubiquitin proteasome system (UPS). The UPS is a …See details»
Outrun Therapeutics | VentureRadar
Website: https://outruntx.com Develops therapies targeting protein stabilization to combat diseases like cancer and neurodegeneration by inhibiting E3 ligase activity and preventing …See details»
Outrun TX - F6S
Outruntx.com. About Outrun TX. Developer of a technology designed for the identification of therapeutics that selectively target the protein degradation pathway. The company provides a …See details»
Outrun Therapeutics launches with a $10m seed financing from M …
Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck.See details»
Recommended Stories - Yahoo Finance
Apr 18, 2024 Outrun Therapeutics ("Outrun"), the E3 ligase inhibitor and protein stabilisation specialist, today exits from stealth following a $10m seed financing round. Outrun's platform …See details»
Our Platform – Outrun Therapeutics
Our platform – X-E 3 L. Outrun’s X-E 3 L (Crosslinking E3 Labeller) platform is scalable and modular, enabling the generation of E3 ligase inhibitors that stabilise proteins.. Despite the …See details»
Outruntx - Company Profile - Tracxn
Oct 24, 2024 Outruntx - Developer of therapeutics for cancer treatment. Raised a total funding of $10M over 1 round from 2 investors. Outruntx has 21 competitors.See details»
Outrun Therapeutics launches with a $10m seed ... - The Malaysian …
Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck. ...See details»
Outruntx - Raised $10M Funding from 2 investors - Tracxn
Nov 5, 2024 Outruntx raised $10M in its latest funding round, which was Seed round held on Apr 18, 2024. How much funding has Outruntx raised till date? Outruntx has raised a total funding …See details»
My Account
Access and manage your Microsoft account and organizations.See details»
Outlook
Get free Outlook email and calendar, plus Office Online apps like Word, Excel and PowerPoint. Sign in to access your Outlook, Hotmail or Live email account.See details»
Our Approach – Outrun Therapeutics
Restoring health by stabilising proteins. Protein stabilisation seeks to maintain the levels of critical proteins and restore the body’s disease suppression processes, returning proteins to …See details»
Log in to your Okta org
If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more.See details»